145 related articles for article (PubMed ID: 36369954)
1. Assessment of immunomodulation and regulation of cell cycle in epithelium and stroma after Cidofovir injection in patients with recurrent respiratory papillomatosis-Pilot study.
Solarz P; Bodnar M; Czech J; Mackiewicz-Nartowicz H; Sinkiewicz A; Szylberg Ł; Borowczak J; Rutkiewicz P; Zwierz A; Burduk P
J Med Virol; 2023 Jan; 95(1):e28303. PubMed ID: 36369954
[TBL] [Abstract][Full Text] [Related]
2. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
Pudszuhn A; Welzel C; Bloching M; Neumann K
Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
[TBL] [Abstract][Full Text] [Related]
3. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
[TBL] [Abstract][Full Text] [Related]
4. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
[TBL] [Abstract][Full Text] [Related]
6. [Cidofovir activity in infantile recurrent respiratory papillomatosis].
Palomar Asenjo V; Palomar García V; Soteras Ollé J; Ruiz Giner A
Acta Otorrinolaringol Esp; 2005 Jan; 56(1):22-4. PubMed ID: 15747720
[TBL] [Abstract][Full Text] [Related]
7. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of HPV DNA copy number in cidofovir therapy of recurrent respiratory papillomatosis.
Major T; Sziklai I; Czeglédy J; Gáll T; Gergely L; Szarka K
Anticancer Res; 2008; 28(4B):2169-74. PubMed ID: 18751391
[TBL] [Abstract][Full Text] [Related]
9. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Mikolajczak S; Quante G; Weissenborn S; Wafaisade A; Wieland U; Lüers JC; Klussmann JP; Beutner D
Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836
[TBL] [Abstract][Full Text] [Related]
10. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children.
Bielecki I; Mniszek J; Cofała M
Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):681-4. PubMed ID: 19193450
[TBL] [Abstract][Full Text] [Related]
11. Intralesional cidofovir for recurrent respiratory papillomatosis in children.
Pransky SM; Magit AE; Kearns DB; Kang DR; Duncan NO
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1143-8. PubMed ID: 10522508
[TBL] [Abstract][Full Text] [Related]
12. Treatment of paediatric laryngeal papillomas: web survey of British Association of Paediatric Otolaryngologists.
Manickavasagam J; Wu K; Bateman ND
J Laryngol Otol; 2013 Sep; 127(9):917-21. PubMed ID: 23927772
[TBL] [Abstract][Full Text] [Related]
13. Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis.
Co J; Woo P
Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):859-62. PubMed ID: 15562893
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
[TBL] [Abstract][Full Text] [Related]
15. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children.
Milczuk HA
Otolaryngol Head Neck Surg; 2003 Jun; 128(6):788-94. PubMed ID: 12825028
[TBL] [Abstract][Full Text] [Related]
16. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
Donne AJ; Rothera MP; Homer JJ
Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].
Snoeck R; Wellens W; Desloovere C; Van Ranst M; Naesens L; De Clercq E; Feenstra L
J Med Virol; 1998 Mar; 54(3):219-25. PubMed ID: 9515772
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.
Dancey DR; Chamberlain DW; Krajden M; Palefsky J; Alberti PW; Downey GP
Chest; 2000 Oct; 118(4):1210-4. PubMed ID: 11035700
[TBL] [Abstract][Full Text] [Related]
19. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
Shehab N; Sweet BV; Hogikyan ND
Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
[TBL] [Abstract][Full Text] [Related]
20. [Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children].
Pontes P; Weckx LL; Pignatari SS; Fujita RR; Avelino MA; Sato J
Rev Assoc Med Bras (1992); 2009; 55(5):581-6. PubMed ID: 19918660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
